Antisense oligonucleotide depletion of CCDC146 is a broad-spectrum therapeutic strategy for ALS is a research paper published in medRxiv (2024). On theSindex it has a DataRank of 0.278. It has been cited 5 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
9.06 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
National Institutes of Health
Grant: 5R01NS097850-09
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD
Wellcome Trust
Grant: 216596
Identifying and verifying non-coding genetic causes of amyotrophic lateral sclerosis
National Institutes of Health
Grant: 5P50HG007735-02
Project 4
National Institutes of Health
Grant: 1R01NS131409-01
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
NHGRI NIH HHS
Grant: P50 HG007735
NINDS NIH HHS
Grant: R01 NS097850
NINDS NIH HHS
Grant: R01 NS131409
Wellcome Trust
Fields of Study
Keywords
Sustainable Development Goals